SEC Tracker
Get the app

Bambusa Therapeutics BBTX

Shanshan Xu (Director) converted 163,596 BBTX at $0.00001, worth $2

Form
4
Filed
Importance
Routine
  1. Shanshan Xu acquired 16,358 common shares
  2. Shanshan Xu acquired 147,238 common shares
  3. MiNeng, Inc. holds 94,050 preferred shares

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Bambusa Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX